Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 11/2007

01.11.2007 | Original Paper

Importance of polymorphisms in NF-κB1 and NF-κBIα genes for melanoma risk, clinicopathological features and tumor progression in Swedish melanoma patients

verfasst von: Huajie Bu, Inger Rosdahl, Xiao-Feng Sun, Hong Zhang

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 11/2007

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Importance of polymorphisms in NF-κB1 and NF-κBIα genes for melanoma risk, clinicopathological features and tumor progression is analyzed in Swedish melanoma patients.

Patients and methods

Functional polymorphisms of NF-κB1 and NF-κBIα genes were examined in 185 melanoma patients and 438 tumor-free individuals. Associations of the polymorphisms with melanoma risk, age and pigment phenotypes of the patients and clinicopathological tumor characteristics were analyzed. DNAs were isolated from mononuclear cells of venous blood. Polymorphisms of the genes were genotyped by a PCR-RFLP technique, and transcription level of NF-κBIα was examined by a quantitative real-time reverse transcription PCR.

Results

Both ATTG insertion polymorphism of NF-κB1 and A to G polymorphism of NF-κBIα genes were correlated with melanoma risk, especially, in a combination of ATTG 2 /ATTGT2 and GG. NF-κB1 ATTG2/ATTG2 and NF-κBIα GG genotypes were associated with male gender and age >65 years (at diagnosis). Patients with ATTG1/ATTG1 genotype had thinner tumors and lower Clark levels at diagnosis. Frequency of ATTG1/ATTG1 genotype was higher in patients with melanomas on intermittently sun-exposed pattern of the body and NF-κBIα GG was more frequent in the patients with melanomas at rarely exposed sites. There were no differences in the gene transcription level between patients with different NF-κBIα genotypes.

Conclusion

NF-κB1 and NF-κBIα genes might be susceptible genes for melanoma risk and functional polymorphisms of these genes might be biological predictors for melanoma progression.
Literatur
Zurück zum Zitat Amiri KI, Richmond A (2005) Role of nuclear factor-kappa B in melanoma. Cancer Metastasis Rev 24(2):301–313PubMedCrossRef Amiri KI, Richmond A (2005) Role of nuclear factor-kappa B in melanoma. Cancer Metastasis Rev 24(2):301–313PubMedCrossRef
Zurück zum Zitat Balch CM, Soong SJ et al (2001) Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19(16):3622–3634PubMed Balch CM, Soong SJ et al (2001) Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 19(16):3622–3634PubMed
Zurück zum Zitat Baldwin AS Jr (1996) The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14:649–683PubMedCrossRef Baldwin AS Jr (1996) The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14:649–683PubMedCrossRef
Zurück zum Zitat Bartkova J, Lukas J et al (1996) The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Cancer Res 56(23):5475–5483PubMed Bartkova J, Lukas J et al (1996) The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Cancer Res 56(23):5475–5483PubMed
Zurück zum Zitat Becker TM, Rizos H et al (2005) Impaired inhibition of NF-kappaB activity by melanoma-associated p16INK4a mutations. Biochem Biophys Res Commun 332(3):873–879PubMedCrossRef Becker TM, Rizos H et al (2005) Impaired inhibition of NF-kappaB activity by melanoma-associated p16INK4a mutations. Biochem Biophys Res Commun 332(3):873–879PubMedCrossRef
Zurück zum Zitat Biswas DK, Cruz AP et al (2000) Epidermal growth factor-induced nuclear factor kappa B activation: a major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells. Proc Natl Acad Sci 97(15):8542–8547PubMedCrossRef Biswas DK, Cruz AP et al (2000) Epidermal growth factor-induced nuclear factor kappa B activation: a major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells. Proc Natl Acad Sci 97(15):8542–8547PubMedCrossRef
Zurück zum Zitat Campbell KJ, Perkins ND (2006) Regulation of NF-kappaB function. Biochem Soc Symp 73:165–180PubMed Campbell KJ, Perkins ND (2006) Regulation of NF-kappaB function. Biochem Soc Symp 73:165–180PubMed
Zurück zum Zitat Chin L (2003) The genetics of malignant melanoma: lessons from mouse and man. Nat Rev Cancer 3(8):559–570PubMedCrossRef Chin L (2003) The genetics of malignant melanoma: lessons from mouse and man. Nat Rev Cancer 3(8):559–570PubMedCrossRef
Zurück zum Zitat Curran JE, Weinstein SR et al (2002) Polymorphic variants of NFKB1 and its inhibitory protein NFKBIA, and their involvement in sporadic breast cancer. Cancer Lett 188(1–2):103–107PubMedCrossRef Curran JE, Weinstein SR et al (2002) Polymorphic variants of NFKB1 and its inhibitory protein NFKBIA, and their involvement in sporadic breast cancer. Cancer Lett 188(1–2):103–107PubMedCrossRef
Zurück zum Zitat Dolcet X, Llobet D et al (2005) NF-kB in development and progression of human cancer. Virchows Arch 446(5):475–482PubMedCrossRef Dolcet X, Llobet D et al (2005) NF-kB in development and progression of human cancer. Virchows Arch 446(5):475–482PubMedCrossRef
Zurück zum Zitat Feinman R, Siegel DS et al (2004) Regulation of NF-kB in multiple myeloma: therapeutic implications. Clin Adv Hematol Oncol 2(3):162–166PubMed Feinman R, Siegel DS et al (2004) Regulation of NF-kB in multiple myeloma: therapeutic implications. Clin Adv Hematol Oncol 2(3):162–166PubMed
Zurück zum Zitat Gilmore TD (2003) The Re1/NF-kappa B/I kappa B signal transduction pathway and cancer. Cancer Treat Res 115:241–265PubMedCrossRef Gilmore TD (2003) The Re1/NF-kappa B/I kappa B signal transduction pathway and cancer. Cancer Treat Res 115:241–265PubMedCrossRef
Zurück zum Zitat Glavac D, Ravnik-Glavac M et al (1994) Polymorphisms in the 3′ untranslated region of the I kappa B/MAD-3 (NFKBI) gene located on chromosome 14. Hum Genet 93(6):694–696PubMedCrossRef Glavac D, Ravnik-Glavac M et al (1994) Polymorphisms in the 3′ untranslated region of the I kappa B/MAD-3 (NFKBI) gene located on chromosome 14. Hum Genet 93(6):694–696PubMedCrossRef
Zurück zum Zitat Goto Y, Yue L et al (2001) A novel single-nucleotide polymorphism in the 3′-untranslated region of the human dihydrofolate reductase gene with enhanced expression. Clin Cancer Res 7(7):1952–1956PubMed Goto Y, Yue L et al (2001) A novel single-nucleotide polymorphism in the 3′-untranslated region of the human dihydrofolate reductase gene with enhanced expression. Clin Cancer Res 7(7):1952–1956PubMed
Zurück zum Zitat Greenlee RT, Hill-Harmon MB et al (2001) Cancer statistics, 2001. CA Cancer J Clin 51(1):15–36PubMed Greenlee RT, Hill-Harmon MB et al (2001) Cancer statistics, 2001. CA Cancer J Clin 51(1):15–36PubMed
Zurück zum Zitat Haluska FG, Housman DE (1995) Recent advances in the molecular genetics of malignant melanoma. Cancer Surv 25:277–292PubMed Haluska FG, Housman DE (1995) Recent advances in the molecular genetics of malignant melanoma. Cancer Surv 25:277–292PubMed
Zurück zum Zitat Houghton AN, Viola MV (1981) Solar radiation and malignant melanoma of the skin. J Am Acad Dermatol 5(4):477–483PubMed Houghton AN, Viola MV (1981) Solar radiation and malignant melanoma of the skin. J Am Acad Dermatol 5(4):477–483PubMed
Zurück zum Zitat Huang S, DeGuzman A et al (2000a) Level of interleukin-8 expression by metastatic human melanoma cells directly correlates with constitutive NF-kappaB activity. Cytokines Cell Mol Ther 6(1):9–17PubMedCrossRef Huang S, DeGuzman A et al (2000a) Level of interleukin-8 expression by metastatic human melanoma cells directly correlates with constitutive NF-kappaB activity. Cytokines Cell Mol Ther 6(1):9–17PubMedCrossRef
Zurück zum Zitat Huang S, DeGuzman A et al (2000b) Nuclear factor-kappaB activity correlates with growth, angiogenesis, and metastasis of human melanoma cells in nude mice. Clin Cancer Res 6(6):2573–2578PubMed Huang S, DeGuzman A et al (2000b) Nuclear factor-kappaB activity correlates with growth, angiogenesis, and metastasis of human melanoma cells in nude mice. Clin Cancer Res 6(6):2573–2578PubMed
Zurück zum Zitat Huang S, Robinson JB et al (2000c) Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8. Cancer Res 60(19):5334–5339PubMed Huang S, Robinson JB et al (2000c) Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8. Cancer Res 60(19):5334–5339PubMed
Zurück zum Zitat Karban AS, Okazaki T et al (2004) Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet 13(1):35–45PubMedCrossRef Karban AS, Okazaki T et al (2004) Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet 13(1):35–45PubMedCrossRef
Zurück zum Zitat Kim LH, Shin HD et al (2003) Identification of variants in NFKBIA and association analysis with hepatocellular carcinoma risk among chronic HBV patients. Hum Mutat 21(6):652–653PubMedCrossRef Kim LH, Shin HD et al (2003) Identification of variants in NFKBIA and association analysis with hepatocellular carcinoma risk among chronic HBV patients. Hum Mutat 21(6):652–653PubMedCrossRef
Zurück zum Zitat Lin SC, Liu CJ et al (2006) Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers. Cancer Lett 243(1):45–47CrossRef Lin SC, Liu CJ et al (2006) Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers. Cancer Lett 243(1):45–47CrossRef
Zurück zum Zitat Mackie RM, Smyth JF et al (1985) Malignant melanoma in Scotland 1979–1983. Lancet 2(8460):859–863PubMedCrossRef Mackie RM, Smyth JF et al (1985) Malignant melanoma in Scotland 1979–1983. Lancet 2(8460):859–863PubMedCrossRef
Zurück zum Zitat Piepkorn MW (1994) Genetic basis of susceptibility to melanoma. J Am Acad Dermatol 31(6):1022–1039PubMedCrossRef Piepkorn MW (1994) Genetic basis of susceptibility to melanoma. J Am Acad Dermatol 31(6):1022–1039PubMedCrossRef
Zurück zum Zitat Richmond A (2002) Nf-kappa B, chemokine gene transcription and tumour growth. Nat Rev Immunol 2(9):664–674PubMedCrossRef Richmond A (2002) Nf-kappa B, chemokine gene transcription and tumour growth. Nat Rev Immunol 2(9):664–674PubMedCrossRef
Zurück zum Zitat Shahbazi M, Pravica V et al (2002) Association between functional polymorphism in EGF gene and malignant melanoma. Lancet 359(9304):397–401PubMedCrossRef Shahbazi M, Pravica V et al (2002) Association between functional polymorphism in EGF gene and malignant melanoma. Lancet 359(9304):397–401PubMedCrossRef
Zurück zum Zitat Shattuck-Brandt RL, Richmond A (1997) Enhanced degradation of I-kappaB alpha contributes to endogenous activation of NF-kappaB in Hs294T melanoma cells. Cancer Res 57(14):3032–3039PubMed Shattuck-Brandt RL, Richmond A (1997) Enhanced degradation of I-kappaB alpha contributes to endogenous activation of NF-kappaB in Hs294T melanoma cells. Cancer Res 57(14):3032–3039PubMed
Zurück zum Zitat Simon MM, Aragane Y et al (1994) UVB light induces nuclear factor kappa B (NF kappa B) activity independently from chromosomal DNA damage in cell-free cytosolic extracts. J Invest Dermatol 102(4):422–427PubMedCrossRef Simon MM, Aragane Y et al (1994) UVB light induces nuclear factor kappa B (NF kappa B) activity independently from chromosomal DNA damage in cell-free cytosolic extracts. J Invest Dermatol 102(4):422–427PubMedCrossRef
Zurück zum Zitat Stierner U, Augustsson A et al (1991) Regional distribution of common and dysplastic naevi in relation to melanoma site and sun exposure. A case-control study. Melanoma Res 1(5–6):367–375 Stierner U, Augustsson A et al (1991) Regional distribution of common and dysplastic naevi in relation to melanoma site and sun exposure. A case-control study. Melanoma Res 1(5–6):367–375
Zurück zum Zitat Winnepenninckx V, Lazer V et al (2006) Gene expression profiling of primary cutaneous melanoma and clinical outcome. J Natl Cancer Inst 98(7):472–482PubMedCrossRef Winnepenninckx V, Lazer V et al (2006) Gene expression profiling of primary cutaneous melanoma and clinical outcome. J Natl Cancer Inst 98(7):472–482PubMedCrossRef
Zurück zum Zitat Yang J, Richmond A (2001) Constitutive IkappaB kinase activity correlates with nuclear factor-kappaB activation in human melanoma cells. Cancer Res 61(12):4901–4909PubMed Yang J, Richmond A (2001) Constitutive IkappaB kinase activity correlates with nuclear factor-kappaB activation in human melanoma cells. Cancer Res 61(12):4901–4909PubMed
Metadaten
Titel
Importance of polymorphisms in NF-κB1 and NF-κBIα genes for melanoma risk, clinicopathological features and tumor progression in Swedish melanoma patients
verfasst von
Huajie Bu
Inger Rosdahl
Xiao-Feng Sun
Hong Zhang
Publikationsdatum
01.11.2007
Verlag
Springer-Verlag
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 11/2007
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-007-0228-7

Weitere Artikel der Ausgabe 11/2007

Journal of Cancer Research and Clinical Oncology 11/2007 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.